| 1 |
31216452 | Aggregate Forms of Recombinant Human Erythropoietin With Different Charge Profile Substantially Impact Biological Activities. | 2020 Jan |
1 |
| 2 |
31767053 | Assessment of methods for determination of glycan composition of erythropoietin. | 2019 |
1 |
| 3 |
28554385 | Co-overexpression of Mgat1 and Mgat4 in CHO cells for production of highly sialylated albumin-erythropoietin. | 2017 Aug |
1 |
| 4 |
23708432 | Mass spectrometric glycoform profiling of the innovator and biosimilar erythropoietin and darbepoetin by LC/ESI-MS. | 2013 Sep |
1 |
| 5 |
22987365 | The impact of sialic acids on the pharmacokinetics of a PEGylated erythropoietin. | 2012 Dec |
1 |
| 6 |
12783618 | Darbepoetin alfa: a new approach to the treatment of chemotherapy-induced anaemia. | 2003 Jun |
1 |
| 7 |
11739166 | Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin. | 2001 Dec 15 |
1 |
| 8 |
10097520 | [Study on evaluating methods for the quality control of glycoprotein products. (II)--Erythropoietin products. Part 2]. | 1998 |
1 |
| 9 |
1560005 | Role of sugar chains in the expression of the biological activity of human erythropoietin. | 1992 Apr 15 |
1 |
| 10 |
2156701 | The role of carbohydrate in recombinant human erythropoietin. | 1990 Mar 10 |
1 |
| 11 |
2269277 | Physicochemical and biological characterization of asialoerythropoietin. Suppressive effects of sialic acid in the expression of biological activity of human erythropoietin in vitro. | 1990 Dec 12 |
2 |